Evidence map›Paper›PMID 39424933›Full record

ArticleCommunications chemistry2024

Steviol rebaudiosides bind to four different sites of the human sweet taste receptor (T1R2/T1R3) complex explaining confusing experiments.

Shuang Hao, Brian Guthrie, Soo-Kyung Kim, Sergej Balanda, Jan Kubicek, Babar Murtaza, Naim A Khan, Pouyan Khakbaz, Judith Su, William A Goddard

Abstract read
In one paragraph

Article in Communications chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shuang HaoWyant College of Optical Sciences and Department of Biomedical Engineering, The University of Arizona, Tucson, AZ, 85721, USA.
Brian GuthrieGlobal Core Research and Development Group, Cargill, Inc. 14800 28th Avenue N, Plymouth, MN, 55447, USA.
Soo-Kyung KimMaterials and Process Simulation Center (MSC), California Institute of Technology, Pasadena, CA, 91125, USA.ORCID http://orcid.org/0000-0002-4498-5441
Sergej BalandaCube Biotech, Creative Campus Monheim, Creative-Campus-Allee 12, 40789, Monheim, Germany.
Jan KubicekCube Biotech, Creative Campus Monheim, Creative-Campus-Allee 12, 40789, Monheim, Germany.
Babar MurtazaPhysiologie de Nutrition & Toxicologie, UB 1231 Center for Translational & Molecular Medicine (CTM), Université de Bourgogne, 21000 Dijon, France.ORCID http://orcid.org/0000-0003-1728-1120
Naim A KhanPhysiologie de Nutrition & Toxicologie, UB 1231 Center for Translational & Molecular Medicine (CTM), Université de Bourgogne, 21000 Dijon, France.ORCID http://orcid.org/0000-0002-8930-9332
Pouyan KhakbazGlobal Core Research and Development Group, Cargill, Inc. 14800 28th Avenue N, Plymouth, MN, 55447, USA.
Judith SuWyant College of Optical Sciences and Department of Biomedical Engineering, The University of Arizona, Tucson, AZ, 85721, USA. judy@optics.arizona.edu.ORCID http://orcid.org/0000-0002-1005-1755
William A GoddardMaterials and Process Simulation Center (MSC), California Institute of Technology, Pasadena, CA, 91125, USA. wag@caltech.edu.ORCID https://orcid.org/0000-0003-0097-5716

Funding

Characterization of biased airway smooth muscle TAS2R agonists for treating asthmaR01HL155532 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI LIGGETT, STEPHEN B · 2021 to 2024
$2.2M
Label-free single molecule detection for basic science and translational medicineR35GM137988 · NIGMS · UNIVERSITY OF ARIZONA · PI SU, JUDITH · 2020 to 2024
$1.8M
NHLBI NIH HHS R01 HL155532NIGMS NIH HHS R35 GM137988U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL155532U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM137988
6 · The paper itself

Abstract

Sucrose provides both sweetness and energy by binding to both Venus flytrap domains (VFD) of the heterodimeric sweet taste receptor (T1R2/T1R3). In contrast, non-caloric sweeteners such as sucralose and aspartame only bind to one specific domain (VFD2) of T1R2, resulting in high-intensity sweetness. In this study, we investigate the binding mechanism of various steviol glycosides, artificial sweeteners, and a negative allosteric modulator (lactisole) at four distinct binding sites: VFD2, VFD3, transmembrane domain 2 (TMD2), and TMD3 through binding experiments and computational docking studies. Our docking results reveal multiple binding sites for the tested ligands, including the radiolabeled ligands. Our experimental evidence demonstrates that the C20 carboxy terminus of the Gα protein can bind to the intracellular region of either TMD2 or TMD3, altering GPCR affinity to the high-affinity state for steviol glycosides. These findings provide a mechanistic understanding of the structure and function of this heterodimeric sweet taste receptor.

Identifiers

PMID39424933
PMCPMC11489721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.